A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma

Description

The purpose of this research study is to assess the ability of AMDX- 2011P to identify amyloid deposits in the retina of participants with Primary Open Angle Glaucoma (POAG).

Conditions

Primary Open Angle Glaucoma

Study Overview

Study Details

Study overview

The purpose of this research study is to assess the ability of AMDX- 2011P to identify amyloid deposits in the retina of participants with Primary Open Angle Glaucoma (POAG).

A Phase 2, Randomized, Open Label Study of AMDX-2011P as a Retinal Tracer in Participants With Primary Open Angle Glaucoma

A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma

Condition
Primary Open Angle Glaucoma
Intervention / Treatment

-

Contacts and Locations

Phoenix

Associated Retina Consultants, Phoenix, Arizona, United States, 85020

Glendale

Global Research Management, Glendale, California, United States, 91204

Newport Beach

Eye Research Foundation, Newport Beach, California, United States, 92663

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Diagnosis of primary open angle glaucoma in both eyes
  • 2. Able to fixate
  • 3. Glaucomatous optic nerve damage in both eyes, as determined by an investigator as part of an eye exam
  • 1. Participants unable to read or write
  • 2. Ocular media is not sufficiently clear to obtain acceptable quality images
  • 3. Participants with presence of any ocular pathology other than glaucoma in the study eye (cataracts are acceptable)

Ages Eligible for Study

22 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Amydis Inc.,

David Bingaman, STUDY_DIRECTOR, Amydis Inc.

Study Record Dates

2025-02